0001213900-20-040310.txt : 20201201
0001213900-20-040310.hdr.sgml : 20201201
20201201190038
ACCESSION NUMBER: 0001213900-20-040310
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201117
FILED AS OF DATE: 20201201
DATE AS OF CHANGE: 20201201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KBL IV SPONSOR LLC
CENTRAL INDEX KEY: 0001706868
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38105
FILM NUMBER: 201362025
BUSINESS ADDRESS:
STREET 1: 527 STANTON CHRISTIANA ROAD
CITY: NEWARK
STATE: DE
ZIP: 19713
BUSINESS PHONE: 3025022727
MAIL ADDRESS:
STREET 1: 527 STANTON CHRISTIANA ROAD
CITY: NEWARK
STATE: DE
ZIP: 19713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KRAUSS MARLENE
CENTRAL INDEX KEY: 0001033308
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38105
FILM NUMBER: 201362026
MAIL ADDRESS:
STREET 1: C/O KBL HEALTHCARE INC
STREET 2: 645 MADISON AVE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 180 Life Sciences Corp.
CENTRAL INDEX KEY: 0001690080
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813832378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 WEST 56TH STREET SUITE 5901
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212-319-5555
MAIL ADDRESS:
STREET 1: 150 WEST 56TH STREET SUITE 5901
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: KBL MERGER CORP. IV
DATE OF NAME CHANGE: 20161115
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0306
4
2020-11-17
0
0001690080
180 Life Sciences Corp.
ATNF
0001033308
KRAUSS MARLENE
30 PARK PLACE, SUITE 64B
NEW YORK
NY
10007
0
0
1
0
0001706868
KBL IV SPONSOR LLC
30 PARK PLACE, SUITE 64B
NEW YORK
NY
10007
0
0
1
0
Common Stock
2020-11-25
4
S
0
12182
2.7753
D
2571556
I
See footnote
Common Stock
2020-11-23
4
S
0
60633
3.2602
D
2583738
I
See footnote
Common Stock
2020-11-19
4
S
0
33445
2.118
D
2644371
I
See footnote
Common Stock
2020-11-18
4
S
0
6700
2.3105
D
2677816
I
See footnote
Common Stock
2020-11-17
4
S
0
3300
2.2562
D
2684516
I
See footnote
The shares are held directly by KBL Sponsor. Dr. Marlene Krauss, the former Chief Executive Officer, and a former memeber of the Board of Directors, of the issuer, is the sole managing member of KBL Sponsor. Consequently, she may be deemed the beneficial owner of the shares of common stock held by KBL Sponsor, and she has sole voting and dispositive control over such securities. Dr. Krauss disclaims beneficial ownership over any securities owned by KBL Sponsor in which she does not have a pecuniary interest.
/s/ Marlene Krauss, M.D.
2020-12-01
/s/ Marlene Krauss, M.D., as Manging Member of KBL IV SPONSOR LLC
2020-12-01